Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 80 citing articles:

Structural Neuroimaging Findings Related to Adult Non-CNS Cancer and Treatment: Review, Integration, and Implications for Treatment of Cognitive Dysfunction
Brenna C. McDonald
Neurotherapeutics (2021) Vol. 18, Iss. 2, pp. 792-810
Open Access | Times Cited: 26
Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: A scoping review
Kate Oppegaard, Terri S. Armstrong, Joaquin A. Anguera, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 180, pp. 103822-103822
Open Access | Times Cited: 17
Structural brain alterations following adult non-CNS cancers: a systematic review of the neuroimaging literature
Ali Amidi, Lisa M. Wu
Acta Oncologica (2019) Vol. 58, Iss. 5, pp. 522-536
Open Access | Times Cited: 26
Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events
Ana Dias-Carvalho, Mariana Ferreira, Rita Ferreira, et al.
Archives of Toxicology (2021) Vol. 96, Iss. 1, pp. 11-78
Closed Access | Times Cited: 21
Advanced MR diffusion imaging and chemotherapy‐related changes in cerebral white matter microstructure of survivors of childhood bone and soft tissue sarcoma?
Charlotte Sleurs, Jurgen Lemiere, Daan Christiaens, et al.
Human Brain Mapping (2018) Vol. 39, Iss. 8, pp. 3375-3387
Open Access | Times Cited: 25
Chemotherapy-induced grey matter abnormalities in cancer survivors: a voxel-wise neuroimaging meta-analysis
Running Niu, Mingying Du, Jing Ren, et al.
Brain Imaging and Behavior (2020) Vol. 15, Iss. 4, pp. 2215-2227
Closed Access | Times Cited: 22
Cognitive complications of cancer and cancer-related treatments – Novel paradigms
Naomi Lomeli, Javier Lepe, Kalpna Gupta, et al.
Neuroscience Letters (2021) Vol. 749, pp. 135720-135720
Open Access | Times Cited: 18
Cancer-related cognitive impairment in non-CNS cancer patients: Targeted review and future action plans in Europe
Charlotte Sleurs, Ali Amidi, Lisa M. Wu, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 180, pp. 103859-103859
Open Access | Times Cited: 13
The chemotherapeutic agent doxorubicin induces brain senescence, with modulation by APOE genotype
Tamar Demby, Phillip S. Gross, Jeanne S. Mandelblatt, et al.
Experimental Neurology (2023) Vol. 371, pp. 114609-114609
Open Access | Times Cited: 7
The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer
Hayley S. Whitford, Paweł Kalinowski, Adrian Schembri, et al.
Supportive Care in Cancer (2019) Vol. 28, Iss. 7, pp. 3081-3091
Closed Access | Times Cited: 20
A mouse model of chemotherapy-related cognitive impairments integrating the risk factors of aging and APOE4 genotype
Tamar Demby, Olga Rodriguez, Camryn W. McCarthy, et al.
Behavioural Brain Research (2020) Vol. 384, pp. 112534-112534
Open Access | Times Cited: 19
Cognitive function is mediated by deficit accumulation in older, long-term breast cancer survivors
Tim A. Ahles, Elizabeth Schofield, Yuelin Li, et al.
Journal of Cancer Survivorship (2023) Vol. 18, Iss. 4, pp. 1243-1251
Closed Access | Times Cited: 6
Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer
Michelle C. Janelsins, Lianlian Lei, Colleen Netherby-Winslow, et al.
Journal of Neuroimmunology (2021) Vol. 362, pp. 577769-577769
Open Access | Times Cited: 15
Brain Hyperconnectivity >10 Years After Cisplatin-Based Chemotherapy for Testicular Cancer
Myrle M. Stouten‐Kemperman, Michiel B. de Ruiter, Willem Boogerd, et al.
Brain Connectivity (2018) Vol. 8, Iss. 7, pp. 398-406
Closed Access | Times Cited: 18
Neurocognitive Function in Adult Cancer Patients
Rebecca A. Harrison, Jeffrey S. Wefel
Neurologic Clinics (2018) Vol. 36, Iss. 3, pp. 653-674
Closed Access | Times Cited: 18
Chemotherapy‐induced toxicity in patients with testicular germ cell tumors: The impact of physical fitness and regular exercise
Ali Amiri, Michal Chovanec, Viktor Oliva, et al.
Andrology (2021) Vol. 9, Iss. 6, pp. 1879-1892
Open Access | Times Cited: 14
Effects of Cancer, Chemotherapy, and Cytokines on Subjective and Objective Cognitive Functioning Among Patients with Breast Cancer
Vincent Chin‐Hung Chen, Chin‐Kuo Lin, Han‐Pin Hsiao, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2576-2576
Open Access | Times Cited: 13
Lack of cognitive impairment in long-term survivors of colorectal cancer
Janette Vardy, Gregory R. Pond, Lucette A. Cysique, et al.
Supportive Care in Cancer (2022) Vol. 30, Iss. 7, pp. 6123-6133
Open Access | Times Cited: 9
Brain cortical structural differences between non-central nervous system cancer patients treated with and without chemotherapy compared to non-cancer controls: a cross-sectional pilot MRI study using clinically indicated scans
Mark S. Shiroishi, Vikash Gupta, Bavrina Bigjahan, et al.
(2017), pp. 61-61
Open Access | Times Cited: 15
Long‐term leukoencephalopathy and neurocognitive functioning in childhood sarcoma patients treated with high‐dose intravenous chemotherapy
Charlotte Sleurs, Jurgen Lemiere, Ahmed Radwan, et al.
Pediatric Blood & Cancer (2019) Vol. 66, Iss. 10
Closed Access | Times Cited: 15
Protective Effects of APOE ε2 Genotype on Cognition in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study
Kathleen Van Dyk, Xingtao Zhou, Brent J. Small, et al.
JNCI Cancer Spectrum (2021) Vol. 5, Iss. 2
Open Access | Times Cited: 12
Cognitive impairment and associations with structural brain networks, endocrine status, and risk genotypes in newly orchiectomized testicular cancer patients
Cecilie R. Buskbjerg, Robert Zachariae, Mads Agerbæk, et al.
Brain Imaging and Behavior (2021) Vol. 16, Iss. 1, pp. 199-210
Closed Access | Times Cited: 11
Neurocognitive Impairment in Non-Central Nervous System Cancer Survivors
Poppy L. A. Schoenberg, Emily M. Mohr, Phyllis E. Kilpatrick, et al.
Journal of Psychophysiology (2024) Vol. 38, Iss. 1, pp. 11-27
Open Access | Times Cited: 1
Neurologic Complications in Adult Cancer Survivorship
Tresa McGranahan, Karl Cristie Figuracion, Myron Goldberg, et al.
Seminars in Neurology (2024) Vol. 44, Iss. 01, pp. 090-101
Closed Access | Times Cited: 1
The impact of APOE and smoking history on cognitive function in older, long-term breast cancer survivors
Tim A. Ahles, Irene Orlow, Elizabeth Schofield, et al.
Journal of Cancer Survivorship (2022) Vol. 18, Iss. 2, pp. 575-585
Open Access | Times Cited: 7

Scroll to top